Madison Memory Study News Today

Quincy Bioscience’s battle with regulators lingered for years in the U.S. courts before the marketer of Prevagen finally had the chance to tell its story before a jury in New York.

In a 7-year-old case that focused on the science behind Prevagen, jurors were introduced to the concept of “competent and reliable scientific evidence.” But Federal Trade Commission guidance only proved to be an important consideration for Quincy, not the state of New York.

A new paper raises concerns about how brain health supplements are marketed to patients suffering with dementia. The paper asserts the most popular products have little scientific backing and aren’t transparent about the dosages of their ingredients